Abstract:Background Mood disorders, including major depressive disorder (MDD) and bipolar disorder (BD), are characterized by severe mood disturbances and have collectively caused a significant burden of diseases. However, diagnosing and distinguishing between the two disorders can be challenging due to the variability of symptoms. Growing evidence in the gut-brain axis has shed light on the connection between gut microbiota, their functions, and the central nervous system, especially for mood disorders. The present study aimed to identify specific microbiota markers associated with MDD and BD in a sample of Han Chinese individuals. Methods We recruited 479 subjects (197 MDD, 158 BD, and 124 healthy controls) and obtained their basic demographic characteristics, dietary factors, and symptom severity data through questionnaires. We performed 16S rRNA sequencing to obtain their microbiota profiles. We compared the microbial diversity between groups by alpha and beta diversity indices. We used multivariate regression analysis to identify differential taxa that could serve as potential biomarkers after adjusting for batch effect, age, BMI, and sex. The correlation between the selected taxa within each group was visualized using a direct force graph, and the correlation between taxa and other variables was assessed through heatmaps. Functional analysis was also performed to explore differences between groups. Furthermore, a co-occurrence network analysis was conducted to investigate the connections between the selected taxa and the functional pathways. Results Patients with MDD or BD exhibited lower alpha diversity and significant beta diversity (p < 0.01) compared to healthy controls across all diversity indices. The abundance of Bacteroidota and Desulfobacterota was reduced in the patients, while Firmicutes were more abundant. At the genus level, we found six taxa, including Bilophila, that were reported in both MDD and BD groups, eight taxa, including Bacteroides, that were specific to MDD patients, and three taxa, including Coprococcus, that were specific to BD patients. Among all groups, Bacteroides had the strongest associations within the correlation network. The two most significant pathways were both related to energy production. Additionally, we found that two important depression-related ways, purine biosynthesis and pyrimidine biosynthesis, were reduced in MDD patients. Bacteroides were associated with energy production pathways and gluconeogenesis in MDD patients, while Coprococcus showed the most associations with identified pathways in BD patients. Discussion Patients with mood disorders showed reduced microbial diversity and distinct microbial composition compared to healthy individuals, supporting previous findings suggesting gut dysbiosis in mood disorder patients. The identified microbiota taxa align with previous studies and could potentially serve as discriminative biomarkers for patients with mood disorders. These specific taxa may also participate in mood disorder-related functional pathways, such as purine and pyrimidine biosynthesis.

Gene Expression Profiling in Peripheral Blood Lymphocytes for Major Depression: Preliminary Cues from Chinese Discordant Sib-Pair Study

Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression

Differential Gene Expression in Patients with Subsyndromal Symptomatic Depression and Major Depressive Disorder

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

BLOOD-BASED GENE EXPRESSION PROFILES FOR CLASSIFICATION OF SUBSYNDROMAL SYMPTOMATIC DEPRESSION AND MAJOR DEPRESSIVE DISORDER

Gene Expression Signatures Differentiating Major Depressive Disorder from Subsyndromal Symptomatic Depression.

Identification of Potential Biomarkers for Major Depressive Disorder: Based on Integrated Bioinformatics and Clinical Validation

Genome-wide profiling of DNA methylome and transcriptome in peripheral blood monocytes for major depression: A Monozygotic Discordant Twin Study

Peripheral Blood Mononuclear Cell Biomarkers for Major Depressive Disorder: A Transcriptomic Approach

Identification of novel endoplasmic reticulum-related genes and their association with immune cell infiltration in major depressive disorder

Key Risk Genes Identified From the Postmortem Brain of Patients With Major Depressive Disorder and Their Potential Clinical Applications

Identification of Key Genes and the Pathophysiology Associated with Major Depressive Disorder Patients Based on Integrated Bioinformatics Analysis

Weighted Gene Co-Expression Network Analysis Identifies Specific Modules and Hub Genes Related to Subsyndromal Symptomatic Depression

Integrated Analysis of Methylomic and Transcriptomic Data to Identify Potential Diagnostic Biomarkers for Major Depressive Disorder

Identification of Diagnostic Markers for Major Depressive Disorder by Cross-Validation of Data from Whole Blood Samples.

A Whole Transcriptome Analysis in Peripheral Blood Suggests That Energy Metabolism and Inflammation Are Involved in Major Depressive Disorder

Genes associated with cellular senescence as diagnostic markers of major depressive disorder and their correlations with immune infiltration

48. THE POTENTIAL MICROBIOTA BIOMARKER AND FUNCTIONAL CHARACTERISTICS BETWEEN PATIENTS WITH MAJOR DEPRESSIVE DISORDER, BIPOLAR DISORDER, AND HEALTHY CONTROLS

Construction and Analysis of a Diagnostic Model Based on Differential Expression Genes in Patients With Major Depressive Disorder

Association of single nucleotide polymorphisms and gene-environment interactions with major depressive disorder in Chinese

Identification of Major Depressive Disorder Disease-Related Genes and Functional Pathways Based on System Dynamic Changes of Network Connectivity.